Recurrent Respiratory Papillomatosis Overview
Save information for later
Sign Up
Learn About Recurrent Respiratory Papillomatosis
What is the definition of Recurrent Respiratory Papillomatosis?
Recurrent respiratory papillomatosis (RRP) is a rare viral disease where tumors (papillomas) grow in the air passages leading from the nose and mouth into the lungs (respiratory tract). There are two types, a juvenile-onset form and an adult-onset form. The tumors can cause a hoarse voice, chronic cough, and difficulty breathing. They may vary in size and grow very quickly, and may grow back even when removed. These tumors rarely become cancerous, but can cause long-term airway and voice complications. RRP is caused by two types of human papillomavirus (HPV), called HPV 6 and HPV 11. It is transmitted from an infected mother to her baby through the placenta or through the birth canal. HPV can also be transmitted from one adult to another through oral sex. The HPV vaccine can help prevent infection.
What are the alternative names for Recurrent Respiratory Papillomatosis?
- Recurrent respiratory papillomatosis
- AORRP (type)
- Adult-onset recurrent respiratory papillomatosis (type)
- JORRP (type)
- Juvenile laryngeal papilloma
- Juvenile-onset recurrent respiratory papillomatosis (type)
- Laryngeal papilloma, recurrent
- RRP
- Respiratory papillomatosis, recurrent
Who are the top Recurrent Respiratory Papillomatosis Local Doctors?
Internal Server Error
Try again later - Or try changing your parameters
Try again later - Or try changing your parameters
What are the latest Recurrent Respiratory Papillomatosis Clinical Trials?
A Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
Enrollment Status: Recruiting
Publish Date: September 02, 2025
Intervention Type: Drug
Study Phase: Phase 2
Background: Recurrent respiratory papillomatosis (RRP) is a rare disease that causes wart-like growths in the airways. These growths come back when removed; some people may need 2 or more surgeries per year to keep their airways clear. Better treatments are needed.
A Phase II Study of Lenvatinib in Combination With Pembrolizumab in HPV-associated Recurrent Respiratory Papillomatosis Patients
Who is this study for: Patients with Recurrent Respiratory Papillomatosis
Enrollment Status: Recruiting
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drugs: Lenvatinib, Pembrolizumab
Study Phase: Phase 2
Summary: This research study is studying Lenvatinib in combination with Pembrolizumab in people with human papillomavirus (HPV)-associated recurrent respiratory papillomatosis (RRP). The names of the study drugs involved in this study are: * Pembrolizumab * Lenvatinib
Who are the sources who wrote this article ?
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center
What are the Latest Advances for Recurrent Respiratory Papillomatosis?
Relación entre genotipo y carga viral de virus del papiloma humano y la gravedad de presentación de la papilomatosis respiratoria recurrente en niños.
Journal: Boletin medico del Hospital Infantil de Mexico
Published: September 25, 2025
An exploratory study of human papillomavirus detection in oral rinses from patients with recurrent respiratory papillomatosis.
Journal: Fukushima journal of medical science
Published: September 03, 2025
Tired of the same old research?
Check Latest Advances
The Derkay Scale as a Predictor of Voice Dysfunction in Recurrent Respiratory Papillomatosis: Correlations Between Acoustic and Patient-Reported Outcomes.
Journal: Journal of clinical medicine
Published: September 02, 2025